Could a lower drug dose be safer and just as effective for kids with rare tumor?
Disease control
Recruiting now
This study compares two doses of sirolimus (low vs high) given with prednisolone to children aged 0-18 who have a rare blood vessel tumor called kaposiform hemangioendothelioma with a serious blood clotting problem (Kasabach-Merritt phenomenon). The goal is to see if the lower do…
Phase: PHASE2, PHASE3 • Sponsor: Yi Ji • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC